M

MNKD

MNKD

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
MNKD Live QuoteReal-time
$3.95
+$0.90(+29.51%)1M
Day Range$3.88 – $4.08
Open$4.07
Previous Close$4.07
Volume4.08M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.27B
P/E Ratio (TTM)24.5
Forward P/E20.9
EPS (TTM)$-0.24
Price to Book187.8
Dividend Yield0.65%
Beta (Volatility)1.09
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $3.95 (40%)
Low: $2.23High: $6.51
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$8.33-94.4% upside

Insider Buys

0

$0

Insider Sales

1

$128K

Total Volume

$128K

1 transactions

Net Activity

$128K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
B
1

Binder Steven B.

Dir

0 buys1 sells

$128K total

Trading History
MNKD insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 25, 2026

1 months ago

Binder Steven B.

Dir

Director
Sell39.1K$3.29$128K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MNKD Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

MNKD has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MNKD

Over the last 90 days, corporate insiders at MNKD (MNKD) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $128K.

The net insider activity for MNKD shows a net selling bias of $128K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Binder Steven B. (Dir), who traded 39.1K shares valued at $128K on Sep 25, 2026.

Live Market News & Developments
Aggregated real-time headlines for MNKD (MNKD)
6 updates

Should You Buy MannKind (MNKD) After Golden Cross?

Zacks Investment ResearchYesterday

MannKind (MNKD) Stock Looks Undervalued On Cash Flow Yet Mixed On Broader Checks

Yahoo Finance118d ago

MNKD - Mannkind Corp Stock Price and Quote

Finviz178d ago

Steven Binder sells $128,477 of MannKind (MNKD) stock

Investing.com53d ago

Is MannKind Corporation (MNKD) A Good Stock To Buy Now?

Yahoo Finance144d ago

MannKind (MNKD) Stock Faces Margin Strain Despite Stronger Product Sales

Simply Wall St105d ago

FAQs About MNKD Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MNKD.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MNKD is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for MNKD is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.